Our own bodies. We’ve sent people to space for decades — but we’re only beginning to learn what that means for their health

Quick Read

The shocking announcement of genetically modified babies creates an opportunity to overhaul the nation’s science, argue Ruipeng Lei and colleagues

Quick Read

If all goes as planned, the first clinical trial in the United States testing CRISPR against cancer by altering the DNA of tumor cells inside patients could begin recruiting participants next year, the scientist leading the effort told STAT

Quick Read

Under a draft proposal, patients would be able to buy some therapies without regulatory approval

Quick Read

But the practical challenges of breeding and maintaining unconventional lab animals persist

Quick Read

“2019 is the year when the training wheels come off and the world gets to see what CRISPR can really do for the world in the most positive sense,” says Fyodor Urnov, a gene-editing scientist at the Altius Institute for Biomedical Sciences in Seattle and the University of California, Berkeley

Quick Read

There’s been a lot of talk about overinvestment in interventions aimed at amyloid in the weeks since Biogen discontinued a late-stage study of aducanumab, an experimental therapy for Alzheimer’s disease

Quick Read

The experimental form of IVF uses an egg from the mother, sperm from the father, and another egg from a donor woman. It was developed to help families affected by deadly mitochondrial diseases which are passed down from mother to baby. It has been tried in only one prior case – a family from Jordan

Quick Read